The ORBITA-COSMIC Trial
Rasha Al-Lamee and Michael Foley sit down with Mamas Mamas to discuss data on an implantable coronary sinus reducer that can ease symptoms in patients with refractory angina.
Related Articles
Wear Red Canada-Halifax Team
I’m raising money for a cause close to my heart and would love your support.
Lindsay’s Big Heart
Lindsay is preparing for her first ballet solo when she suddenly feels funny and collapses. Through her journey to see what happened, she visits the…
Program Guide | THT 2025 | Boston
View the THT 2025 Program Guide: heart failure emerging tehnologies, AI in heart failure, complex cases, gene therapy, innovation, new research, training.
Propranolol Linked to Stroke Protection in Women With Migraine
Part of the benefit may be due to BP-lowering effects of the drug and/or fewer abnormal heart rhythms, says Seemant Chaturvedi.
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma | NEJM
We describe two patients in whom malignant monoclonal T-cell lymphoproliferation developed after administration of chimeric antigen receptor (CAR) T-cell therapy with ciltacabtagene autoleucel (cil…
US warns its citizens to avoid Islamabad’s Faisal Mosque area
The US embassy’s latest travel advisory cites threats by the outlawed terrorist group Tehreek-e-Taliban Pakistan.
Welcome | – American College of Cardiology
Course Chair, Richard Cheng, MD, MSc, FACC and Vice-Chair, Anju Nohria, MD, MSc are excited to bring together cardiologists, oncologists, internists, pharmacists, nurses, and all members of…
Buckling Under Pressure: Evolut FX Delivery System Malfunction and Failure to Recapture During TAVR
AbstractObjectiveWe present a case of transcatheter aortic valve replacement in a 70-year-old woman with severe bicuspid aortic valve stenosis complicated by incomplete recapture of the…
Comparative Effects of Glenzocimab and Eptifibatide on Bleeding Severity in 2 Mouse Models of Intracranial Hemorrhage | Journal of the American Heart Association
BackgroundAntiplatelet drugs represent potential candidates for protecting the penumbral microcirculation during cerebral ischemia and improving the benefits of arterial recanalization in ischemic …
Report: Johnson & Johnson wants to sell its stroke business for more than $1B
Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus division of stroke products.
